Navigation Links
Accuray Receives Prestigious Awards for 2008 Advertising Campaign
Date:1/7/2009

ADDY and Telly Awards Honor CyberKnife Print and TV Ads

SUNNYVALE, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced the company has received three prestigious awards for its 2008 advertising campaign promoting the CyberKnife(R) Robotic Radiosurgery System.

Accuray and RBG Marketing, who created the ads, received recognition from the world-renowned ADDY(R) Awards for their patient-focused print campaign and recognition from the Telly Awards for their television commercial.

Accuray and RBG Marketing received Silver ADDY Awards at both the local chapter and district level for their "Tumors Have Nowhere to Hide" print series, which featured actual patients who were treated with the CyberKnife System. The companies also received a Bronze ADDY Award at the local chapter level for "The Fight of My Life" print campaign, which worked in conjunction with their award-winning television commercial.

The ADDY Awards, presented by the American Advertising Federation, is the world's largest advertising competition. With more than 60,000 entries annually, the ADDY Awards epitomize creative excellence by recognizing all forms of advertising from all types of media, created by all sizes and levels of entrants from anywhere in the world. It is the only creative awards program administered by and for the advertising industry.

"Accuray's receipt of these prestigious awards, in partnership with RBG Marketing, is a testament to the creativity and innovation we bring to all facets of our business," said Eric P. Lindquist, senior vice president and chief marketing officer of Accuray. "Since advertising is one way to spread awareness of the benefits of the CyberKnife System we are pleased that these tools have not only achieved that purpose but they've also been recognized as being best in class."

Additionally, Accuray and RBG Marketing received a Telly Award for the company's television commercial, which was made available to local CyberKnife facilities to air within their local markets. The commercial featured a boxer sharing the emotions one goes through when they learn of their cancer diagnosis. The boxer speaks directly to his cancer and displays the "fighting" attitude that many cancer patients adopt after they go through the shock and acceptance of their condition. The boxer hopes to inspire, encourage and educate newly diagnosed patients who may need a new type of treatment.

The Telly Awards honor the best local, regional, and cable television commercials and programs, as well as the finest video and film productions, and work created for the Web.

About RBG Marketing

Headquartered in Walnut Creek, Calif., RBG Marketing Inc. specializes in creating integrated marketing programs for the healthcare and retail industries. The company's Results Builder(TM) process mixes rigorous thinking, boundless imagination, focused strategy and tangible measurement to deliver exceptional "Impactfully Simple" creative to help clients meet their unique business objectives. For more information and samples, visit www.RBGmarketing.com

About the CyberKnife(R) Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 50,000 patients worldwide and currently more than 150 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit www.accuray.com.

Safe Harbor Statement

The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, including statements relating to commercialization of products, clinical studies, regulatory review and approval are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: market acceptance of products; competing products, the combination of our products with complementary technology; and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for the 2008 fiscal year, as updated in our Form 10-Q filed on December 19, 2008 and our other filings with the Securities and Exchange Commission. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.


'/>"/>
SOURCE Accuray Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery
2. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
3. Accuray to Webcast Senior Management Presentations at Analyst Day Event
4. Accuray Incorporated to Report First Quarter Fiscal Year 2008 Financial Results
5. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO 2007
6. Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting
7. Accuray Reports Record Revenue in First Quarter of Fiscal 2008
8. Accuray Exceeds 4,000 Lung Cancer Patients Treated with CyberKnife(R) System
9. Accuray Incorporated to Report Second Quarter Fiscal Year 2008 Financial Results
10. Accuray Reports Continued Growth in Second Quarter of Fiscal 2008
11. Accurays CyberKnife System Receives 2008 North American Medical Devices Product of the Year Award From Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
Breaking Medicine Technology: